Please Wait...

Clinical Adjudication

Bioclinica's Clinical Adjudication Service provides a key role in determining the efficacy and safety endpoints needed to analyze clinical trial outcomes, which are necessary in determining clinical trial success.

Clinical Adjudication

Flexible modeling of any adjudication pathway coupled with transparency of workflow status along with immediate data accessibility

Determining acceptable safety results during a clinical trial by way of independent electronic event adjudication committees is the most efficient process to assist sponsors in reducing costs, increasing quality, and eliminating clinical bias. Bioclinica's Clinical Adjudication Service provides sponsors with the ability to electronically manage safety endpoints from notification of an endpoint at a clinical trial site through central review by therapeutic experts. This allows for an efficient and streamlined process that ensures high quality and timely results. Therapeutic expertise backed by automated technology enables continuous adjudication with real-time results.

Bioclinica's Clinical Adjudication Service is completely customizable in order to best meet a sponsor's adjudication requirements. Our vast library of eCRF logic and safety and efficacy parameters is designed to meet adjudicator, sponsor, and regulatory data delivery compliance needs.

Bioclinica's Clinical Adjudication Service benefits to a sponsor:

THOUGHT LEADERSHIP

  • Comprehensive medical expertise across all therapeutic areas
  • Uniform event definition across all event types
  • Ensures site compliance with event reporting
  • Efficient and automated adjudication workflows
  • Real-time access to data enabling faster adjudication
  • Ease of electronic process reducing manual errors and costs
  • Real-time online access to adjudication results and data reports
  • Data visualization of research site, user and adjudicator performance metrics
  • Integrated global language translation and redaction services
  • 24/7/365 live support

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Handy guide for the pharmacovigilance folks! https://t.co/tOyQWkiNhW
bioclinica (Yesterday)
#ClinicalResearch sites, REJOICE @bioclinica SMART Submit 4 cloud rsch image mgmt /subm is here! @OutsourcPharmahttp://ow.ly/odCh30grhnY
bioclinica (Yesterday)
What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (2 days ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (3 days ago)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (3 days ago)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (3 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices